N E Kaminski
Overview
Explore the profile of N E Kaminski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jan T, Kaminski N
J Leukoc Biol
. 2001 May;
69(5):841-9.
PMID: 11358994
Cannabinoids can paradoxically regulate interleukin-2 (IL-2) expression either positively or negatively. This study investigated the mechanism responsible for cannabinol-mediated IL-2 modulation. In primary murine splenocytes and EL4.IL-2 T cells, the...
2.
Li X, Kaminski N, Fischer L
Int Immunopharmacol
. 2001 May;
1(4):699-712.
PMID: 11357882
delta9-Tetrahydrocannabinol (delta9-THC) is capable of modulating a variety of immune responses, but has not been evaluated in models of immune-based diabetes. The objectives of the present study were: (a) to...
3.
HERRING A, Faubert Kaplan B, Kaminski N
Cell Signal
. 2001 Apr;
13(4):241-50.
PMID: 11306241
Cannabinoid compounds inhibit the cAMP signalling cascade in leukocytes. One of these compounds, cannabinol (CBN) has been shown to inhibit interleukin-2 (IL-2) expression and the activation of cAMP response element...
4.
Sulentic C, Holsapple M, Kaminski N
J Pharmacol Exp Ther
. 2000 Oct;
295(2):705-16.
PMID: 11046109
The B-cell, a major cellular component of humoral immunity, has been identified as a sensitive target of 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD). The actual molecular mechanism responsible for the immunotoxic effects produced...
5.
McKarns S, Kaminski N
Immunopharmacology
. 2000 Aug;
48(2):101-15.
PMID: 10936508
Transforming growth factor-beta(1) (TGF-beta(1)) is a critical bifunctional regulator of inflammatory responses. Evidence strongly suggests that these regulatory consequences are, at least in part, a result of profound pleiotropic effects...
6.
Faubert B, Kaminski N
J Leukoc Biol
. 2000 Feb;
67(2):259-66.
PMID: 10670588
Regulation of the activator protein-1 (AP-1) complex is very intricate because it involves phosphorylation state, protein-protein, and protein-DNA interactions. In these studies, the regulation of AP-1 activity, with emphasis on...
7.
Yea S, Yang K, Kaminski N
J Pharmacol Exp Ther
. 2000 Jan;
292(2):597-605.
PMID: 10640296
We previously reported that immunosuppressive cannabinoids inhibited interleukin (IL)-2 steady-state mRNA expression and secretion by phorbol-12-myristate-13-acetate plus ionomycin-activated mouse splenocytes and EL4 murine T-cells. Here we show that inhibition of...
8.
HERRING A, Kaminski N
J Pharmacol Exp Ther
. 1999 Nov;
291(3):1156-63.
PMID: 10565837
Cannabinol (CBN), an immunosuppressive cannabinoid and ligand for the peripheral cannabinoid receptor CB2, inhibits the cAMP signaling cascade in forskolin-stimulated thymocytes. The objective of the present studies was to further...
9.
Smeets J, Rankouhi T, Nichols K, Komen H, Kaminski N, Giesy J, et al.
Toxicol Appl Pharmacol
. 1999 May;
157(1):68-76.
PMID: 10329509
The yolk protein precursor vitellogenin (Vtg) is secreted by the liver of female as well as male fish, in response to estrogenic compounds. In this study, an in vitro assay...
10.
Ouyang Y, Kaminski N
Arch Toxicol
. 1999 Apr;
73(1):1-6.
PMID: 10207608
Phospholipase A2 (PLA2) has been postulated to play a role in the regulation of cytokine expression. Therefore, the objective of the present study was to investigate the effects of PLA2...